《曲妥珠单抗耐药胃癌潜在关键基因的生物信息学分析》勘误
Corrigendum to "Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer".
作者信息
Yang Guangda, Jian Liumeng, Lin Xiangan, Zhu Aiyu, Wen Guohua
机构信息
Department of Cancer Chemotherapy, Zengcheng District People's Hospital of Guangzhou (BoJi-Affiliated Hospital of Sun Yat-sen University), Guangzhou, China.
Department of Neurology, Zengcheng District People's Hospital of GuangZhou (BoJi-Affiliated Hospital of Sun Yat-sen University), Guangzhou, China.
出版信息
Dis Markers. 2020 Dec 24;2020:3147825. doi: 10.1155/2020/3147825. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1155/2019/1372571.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2019/1372571。]
相似文献
1
Corrigendum to "Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer".《曲妥珠单抗耐药胃癌潜在关键基因的生物信息学分析》勘误
Dis Markers. 2020 Dec 24;2020:3147825. doi: 10.1155/2020/3147825. eCollection 2020.
2
Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.勘误：通过综合生物信息学分析，长链非编码RNA MSC-AS1是胃癌患者的诊断生物标志物并预测不良预后。
Front Med (Lausanne). 2022 Feb 17;9:862010. doi: 10.3389/fmed.2022.862010. eCollection 2022.
3
Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.曲妥珠单抗耐药性胃癌中潜在关键基因的生物信息学分析。
Dis Markers. 2019 Dec 17;2019:1372571. doi: 10.1155/2019/1372571. eCollection 2019.
4
Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis.基于生物信息学分析鉴定 COL4A1 为胃癌曲妥珠单抗耐药的潜在基因。
Mol Med Rep. 2018 May;17(5):6387-6396. doi: 10.3892/mmr.2018.8664. Epub 2018 Mar 1.
5
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.预测曲妥珠单抗耐药性胃癌相关的关键基因和通路。
World J Surg Oncol. 2018 Aug 22;16(1):174. doi: 10.1186/s12957-018-1475-6.
6
Corrigendum: Bioinformatics Analysis Identififies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs.勘误：生物信息学分析鉴定出调控子宫内膜异位症发生发展的分子标志物及潜在治疗药物。
Front Genet. 2022 Jan 5;12:793656. doi: 10.3389/fgene.2021.793656. eCollection 2021.
7
Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".《化疗药物与线粒体功能障碍：聚焦阿霉素、曲妥珠单抗和舒尼替尼》勘误
Oxid Med Cell Longev. 2019 Jun 26;2019:9601435. doi: 10.1155/2019/9601435. eCollection 2019.
8
Corrigendum: Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.勘误：综合生物信息学与验证揭示与原发性干燥综合征进展相关的潜在生物标志物。
Front Immunol. 2021 Sep 29;12:759203. doi: 10.3389/fimmu.2021.759203. eCollection 2021.
9
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.勘误：HER2阳性乳腺癌新辅助曲妥珠单抗化疗后基线和残留肿瘤中的PAM50亚型：来自单一机构的连续系列研究。
Front Oncol. 2019 Sep 25;9:967. doi: 10.3389/fonc.2019.00967. eCollection 2019.
10
Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.勘误：生物信息学分析揭示胃腺癌中癌细胞干性、基因突变与免疫微环境之间的关联。
Front Genet. 2022 Feb 14;13:828664. doi: 10.3389/fgene.2022.828664. eCollection 2022.
引用本文的文献
1
The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.C 反应蛋白与白蛋白比值是接受经动脉化疗栓塞治疗的肝细胞癌患者的独立预后因素：一项大型队列研究。
Cardiovasc Intervent Radiol. 2022 Sep;45(9):1295-1303. doi: 10.1007/s00270-022-03208-w. Epub 2022 Jul 14.
本文引用的文献
1
Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.曲妥珠单抗耐药性胃癌中潜在关键基因的生物信息学分析。
Dis Markers. 2019 Dec 17;2019:1372571. doi: 10.1155/2019/1372571. eCollection 2019.
2
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.预测曲妥珠单抗耐药性胃癌相关的关键基因和通路。
World J Surg Oncol. 2018 Aug 22;16(1):174. doi: 10.1186/s12957-018-1475-6.
Zotero 插件